Alnylam grants CEO Greenstreet performance-based PSUs tied to $500-$800 stock price by 2029

ALNYLAM PHARMACEUTICALS, INC.

Target of 55,373 PSUs ($18.0M face value at $325.07 close on grant date).
Vesting requires 30-day avg stock price of $500 (50% vest) to $800 (200% vest) by Dec 31, 2029.
Baseline threshold of $500 exceeds all-time high; award forfeited if price below $500.
Special award granted alongside annual equity, designed with independent compensation consultant.
Under Greenstreet, Alnylam achieved ~100% stockholder return, AMVUTTRA approval, and 2025 profitability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.